Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Revenue		$ 447,605	$ 429,909	$ 396,289
Total cost of revenue	[1]	293,645	269,954	236,782
Research and development	[2]	57,129	57,752	52,729
Products
Revenue	[3]	233,192	214,715	176,647
Total cost of revenue		153,627	127,287	102,100
Services
Revenue	[4]	214,413	215,194	219,642
Total cost of revenue		140,018	142,667	134,682
Revenue from Joint Venture
Total cost of revenue		37,772	35,237	13,310
Research and development		1,463	2,336	430
Revenue from Joint Venture | Products
Revenue		55,658	45,545	12,033
Revenue from Joint Venture | Services
Revenue		$ 10,919	$ 10,332	$ 12,360

[1] Includes cost of revenue from sales to the joint venture, an equity method investment, of $37,772 during the year ended June 30, 2023, $35,237 during the year ended June 30, 2022, and $13,310 during the year ended June 30, 2021, respectively. See Note 11.

[2] Includes charge backs to the joint venture, an equity method investment, related to research and development of $1,463 during the year ended June 30, 2023, $2,336 during the year ended June 30, 2022, and $430 during the year ended June 30, 2021, respectively.

[3] Includes sales of products to the joint venture, an equity method investment, of $55,658 during the year ended June 30, 2023, $45,545 during the year ended June 30, 2022, and $12,033 during the year ended June 30, 2021, respectively. See Note 11.

[4] Includes sales of services to the joint venture, an equity method investment, of $10,919 during the year ended June 30, 2023, $10,332 during the year ended June 30, 2022, and $12,360 during the year ended June 30, 2021, respectively. See Note 11.